ProfileGDS4718 / 1552694_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 21% 58% 26% 31% 25% 13% 4% 42% 24% 32% 31% 33% 16% 11% 8% 33% 36% 10% 20% 6% 40% 41% 54% 24% 34% 11% 18% 10% 42% 6% 15% 6% 63% 61% 4% 7% 19% 45% 30% 31% 31% 4% 3% 1% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2098821
GSM549102patient 115, normal, homogenized [OPG study]5.990158
GSM549104patient 119, normal, homogenized [OPG study]4.3465226
GSM549108patient 138, normal, homogenized [OPG study]4.6339331
GSM549119patient 077, normal, homogenized [OPG study]4.3418125
GSM549133patient 032, cancer, homogenized [OPG study]3.8579113
GSM549139patient 042, cancer, homogenized [OPG study]3.527934
GSM549099patient 107, normal, homogenized [OPG study]5.0907942
GSM549109patient 139, normal, homogenized [OPG study]4.313324
GSM549110patient 046, normal, homogenized [OPG study]4.6217132
GSM549114patient 063, normal, homogenized [OPG study]4.5470131
GSM549122patient 082, normal, homogenized [OPG study]4.6618333
GSM549134patient 033, cancer, homogenized [OPG study]3.9825116
GSM549136patient 036, cancer, homogenized [OPG study]3.7755911
GSM549140patient 044, cancer, homogenized [OPG study]3.65978
GSM549111patient 047, normal, homogenized [OPG study]4.6200233
GSM549113patient 057, normal, homogenized [OPG study]4.7675636
GSM549132patient 031, cancer, homogenized [OPG study]3.7698210
GSM549137patient 038, cancer, homogenized [OPG study]4.1373120
GSM549142patient 047, cancer, homogenized [OPG study]3.664126
GSM549100patient 110, normal, homogenized [OPG study]5.0027240
GSM549107patient 135, normal, homogenized [OPG study]5.0145741
GSM549115patient 068, normal, homogenized [OPG study]5.6808654
GSM549116patient 072, normal, homogenized [OPG study]4.2967724
GSM549120patient 078, normal, homogenized [OPG study]4.6893634
GSM549131patient 030, cancer, homogenized [OPG study]3.7886211
GSM549118patient 074, normal, homogenized [OPG study]4.0849718
GSM549129patient 027, cancer, homogenized [OPG study]3.7801810
GSM549123patient 088, normal, homogenized [OPG study]5.0480742
GSM549124patient 006, cancer, homogenized [OPG study]3.640666
GSM549126patient 015, cancer, homogenized [OPG study]3.9375815
GSM549128patient 025, cancer, homogenized [OPG study]3.609026
GSM549103patient 117, normal, homogenized [OPG study]6.3356163
GSM549117patient 073, normal, homogenized [OPG study]6.1360561
GSM549138patient 041, cancer, homogenized [OPG study]3.504044
GSM549141patient 045, cancer, homogenized [OPG study]3.62877
GSM549130patient 028, cancer, homogenized [OPG study]4.1254519
GSM549101patient 111, normal, homogenized [OPG study]5.2503545
GSM549105patient 128, normal, homogenized [OPG study]4.5716830
GSM549106patient 134, normal, homogenized [OPG study]4.5289331
GSM549112patient 048, normal, homogenized [OPG study]4.5926431
GSM549125patient 011, cancer, homogenized [OPG study]3.535994
GSM549127patient 024, cancer, homogenized [OPG study]3.437473
GSM549135patient 035, cancer, homogenized [OPG study]3.339051